In rheumatoid arthritis (RA), the NF-κB signaling pathway is frequently observed to be significantly activated and the reduced NF-κB activity results in decreased production of matrix metalloproteinases, which contributes to the attenuation of joint damage. The gene discussed is NFKB1; the disease is rheumatoid arthritis.